Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Exploring the immunome: A brave new world for human vaccine development.

De Groot AS.

Hum Vaccin. 2009 Dec;5(12):790-3. Epub 2009 Dec 15. No abstract available.

2.

Predicting vaccine responsiveness.

Boyd SD, Jackson KJ.

Cell Host Microbe. 2015 Mar 11;17(3):301-7. doi: 10.1016/j.chom.2015.02.015. Review.

3.

Reverse vaccinology: developing vaccines in the era of genomics.

Sette A, Rappuoli R.

Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017. Review.

4.

Prime-boost immunization strategies for infectious diseases.

McShane H.

Curr Opin Mol Ther. 2002 Feb;4(1):23-7. Review.

PMID:
11883691
5.

Cell-mediated immunity needed for TB vaccine.

[No authors listed]

Indian J Med Sci. 1998 Nov;52(11):521-2. No abstract available.

PMID:
10218297
6.

Deciphering the human antigenome.

Sette A, Schenkelberg TR, Koff WC.

Expert Rev Vaccines. 2016;15(2):167-71. doi: 10.1586/14760584.2016.1112743. Epub 2015 Dec 2.

PMID:
26629807
7.

Vaccine adjuvants: current challenges and future approaches.

Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B.

J Pharm Sci. 2009 Apr;98(4):1278-316. doi: 10.1002/jps.21523. Review.

PMID:
18704954
8.

Methods for assessing cell-mediated immunity in infectious disease resistance and in the development of vaccines.

Clough NE, Roth JA.

J Am Vet Med Assoc. 1995 Apr 15;206(8):1208-16. Review. No abstract available.

PMID:
7768746
9.

Taking aim at novel vaccines market.

Awasthi S.

Hum Vaccin. 2009 Oct;5(10):654-7. Epub 2009 Oct 1.

PMID:
19855156
10.

Genomics and proteomics: emerging technologies in clinical cancer research.

Chung CH, Levy S, Chaurand P, Carbone DP.

Crit Rev Oncol Hematol. 2007 Jan;61(1):1-25. Epub 2006 Oct 2. Review.

PMID:
17015021
11.

From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.

Mortellaro A, Ricciardi-Castagnoli P.

Immunol Cell Biol. 2011 Mar;89(3):332-9. doi: 10.1038/icb.2010.152. Epub 2011 Feb 8. Review.

PMID:
21301476
12.

Research resources for tuberculosis at the National Institute of Allergy and Infectious Diseases.

NIH, DMID TB program.

Tuberculosis (Edinb). 2013 Jan;93(1):6-11. doi: 10.1016/j.tube.2012.11.009. Epub 2013 Feb 4. Review.

PMID:
23385001
13.

Bioinformatics: biology by other means.

Valencia A.

Bioinformatics. 2002 Dec;18(12):1551-2. No abstract available.

PMID:
12490437
14.

The use of genomics in microbial vaccine development.

Bambini S, Rappuoli R.

Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15. Review.

PMID:
19150507
15.

Edward Jenner Institute for Vaccine Research--third international meeting: 12-16 April 2003, Oxford, UK.

Williams NA.

IDrugs. 2003 Jun;6(6):527-30. No abstract available.

PMID:
12861977
16.

Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases.

Terry FE, Moise L, Martin RF, Torres M, Pilotte N, Williams SA, De Groot AS.

Expert Rev Vaccines. 2015 Jan;14(1):21-35. doi: 10.1586/14760584.2015.955478. Epub 2014 Sep 5. Review.

17.

Immunomics: a 21st century approach to vaccine development for complex pathogens.

De Sousa KP, Doolan DL.

Parasitology. 2016 Feb;143(2):236-44. doi: 10.1017/S0031182015001079. Review.

PMID:
26864136
18.

Quest for the AIDS vaccine.

Tonks A.

BMJ. 2007 Jun 30;334(7608):1346-8. Review. No abstract available.

19.

Exploring functional genomics for the development of novel intervention strategies against tuberculosis.

Rachman H, Kaufmann SH.

Int J Med Microbiol. 2007 Nov;297(7-8):559-67. Epub 2007 Apr 27. Review.

PMID:
17467338
20.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921

Supplemental Content

Support Center